Literature DB >> 1673787

Poliovirus can enter and infect mammalian cells by way of an intercellular adhesion molecule 1 pathway.

H C Selinka1, A Zibert, E Wimmer.   

Abstract

Mouse fibroblast cell lines were transfected with truncated forms of the human poliovirus receptor (PVR) cDNA and tested for the expression of functional receptors for poliovirus. Several receptor constructs, all containing the coding region of the first 143 amino acids of PVR, were able to render mouse cells susceptible to poliovirus infection. A deletion of 65 amino acids in the first extracellular domain of PVR prevented virus attachment and infection. These data suggest that domain 1 is necessary and sufficient for the virus-receptor interaction. A PVR/intercellular adhesion molecule 1 hybrid receptor, expressing the PVR variable domain on a truncated receptor molecule for human rhinovirus 14, was shown to be a functional receptor for poliovirus. This observation indicates that, subsequent to attachment to the PVR-binding domain, poliovirus can use the same pathway as the major receptor group rhinoviruses to enter cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673787      PMCID: PMC51499          DOI: 10.1073/pnas.88.9.3598

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Capsid protein VP4 of poliovirus is N-myristoylated.

Authors:  A V Paul; A Schultz; S E Pincus; S Oroszlan; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

3.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

4.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding.

Authors:  R J Colonno; J H Condra; S Mizutani; P L Callahan; M E Davies; M A Murcko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Transformation of a human poliovirus receptor gene into mouse cells.

Authors:  C Mendelsohn; B Johnson; K A Lionetti; P Nobis; E Wimmer; V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

Authors:  R B Ren; F Costantini; E J Gorgacz; J J Lee; V R Racaniello
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

7.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Authors:  G Fox; N R Parry; P V Barnett; B McGinn; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

9.  The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

Authors:  S Koike; H Horie; I Ise; A Okitsu; M Yoshida; N Iizuka; K Takeuchi; T Takegami; A Nomoto
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  The mammalian cell-virus relationship. IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid.

Authors:  J J HOLLAND; L C McLAREN; J T SYVERTON
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

View more
  37 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Three-dimensional structure of poliovirus receptor bound to poliovirus.

Authors:  D M Belnap; B M McDermott; D J Filman; N Cheng; B L Trus; H J Zuccola; V R Racaniello; J M Hogle; A C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Interaction of the poliovirus receptor with poliovirus.

Authors:  Y He; V D Bowman; S Mueller; C M Bator; J Bella; X Peng; T S Baker; E Wimmer; R J Kuhn; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 4.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

5.  Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Authors:  Stefan Freigang; Denise Egger; Kurt Bienz; Hans Hengartner; Rolf M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

6.  A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells.

Authors:  H C Selinka; A Zibert; E Wimmer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex.

Authors:  Doryen Bubeck; David J Filman; James M Hogle
Journal:  Nat Struct Mol Biol       Date:  2005-06-19       Impact factor: 15.369

Review 8.  Will complex carbohydrate ligands of vascular selectins be the next generation of non-steroidal anti-inflammatory drugs?

Authors:  J L Winkelhake
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

9.  Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.

Authors:  Ping Zhang; Steffen Mueller; Marc C Morais; Carol M Bator; Valorie D Bowman; Susan Hafenstein; Eckard Wimmer; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

10.  Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.

Authors:  E Rieder; A Berinstein; B Baxt; A Kang; P W Mason
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.